Cargando…
Reciprocal regulation of the cholinic phenotype and epithelial-mesenchymal transition in glioblastoma cells
Glioblastoma (GBM) is the most malignant brain tumor with very limited therapeutic options. Standard multimodal treatments, including surgical resection and combined radio-chemotherapy do not target the most aggressive subtype of glioma cells, brain tumor stem cells (BTSCs). BTSCs are thought to be...
Autores principales: | Koch, Katharina, Hartmann, Rudolf, Schröter, Friederike, Suwala, Abigail Kora, Maciaczyk, Donata, Krüger, Andrea Caroline, Willbold, Dieter, Kahlert, Ulf Dietrich, Maciaczyk, Jaroslaw |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5341988/ https://www.ncbi.nlm.nih.gov/pubmed/27705917 http://dx.doi.org/10.18632/oncotarget.12337 |
Ejemplares similares
-
Overexpression of Cystine/Glutamate Antiporter xCT Correlates with Nutrient Flexibility and ZEB1 Expression in Highly Clonogenic Glioblastoma Stem-like Cells (GSCs)
por: Koch, Katharina, et al.
Publicado: (2021) -
Inhibition of Wnt/beta-catenin signaling downregulates expression of aldehyde dehydrogenase isoform 3A1 (ALDH3A1) to reduce resistance against temozolomide in glioblastoma in vitro
por: Suwala, Abigail Kora, et al.
Publicado: (2018) -
Enzymatic Activity of CD73 Modulates Invasion of Gliomas via Epithelial–Mesenchymal Transition-Like Reprogramming
por: Tsiampali, Julia, et al.
Publicado: (2020) -
Characterization of a Setup to test the Impact of High-Amplitude Pressure Waves on Living Cells
por: Schmidt, Mischa, et al.
Publicado: (2014) -
A comparative pharmaco-metabolomic study of glutaminase inhibitors in glioma stem-like cells confirms biological effectiveness but reveals differences in target-specificity
por: Koch, Katharina, et al.
Publicado: (2020)